Neogen Chemicals Q3 FY26 Earnings Presentation: Focus on Battery Materials & Expansion
Neogen Chemicals reported Q3 FY26 consolidated revenue of ₹220 crore, up 9% YoY. PAT declined due to fire-related costs and expansionary spends. The company is progressing on its ₹1,500 crore battery materials expansion, with a JV with Japan's Morita Investment. A ₹150 crore preferential issue is approved to reinforce promoter commitment.
The announcement details significant future growth plans in the battery chemicals sector and a substantial expansion CAPEX. However, the reported quarter's financial results show a decline in profitability due to specific, albeit temporary, cost headwinds. The preferential issue also indicates a focus on strengthening finances for growth.
While the company is strategically expanding into battery materials and has a joint venture, the reported Q3 FY26 results show a significant decline in Profit After Tax due to specific cost pressures and fire-related expenses. The future outlook is positive, but current financial performance is impacted.
Neogen Chemicals Limited has released its Earnings Presentation for the quarter and nine months ended December 31, 2025. The presentation details financial performance, expansion initiatives, and strategic outlook.
Financially, for Q3 FY26, consolidated revenue stood at ₹220.0 crore, an increase of 9% year-on-year, while standalone revenue was ₹215.6 crore, up 8%. Consolidated EBITDA was ₹31.9 crore, an 8% decrease, and standalone EBITDA was ₹36.3 crore, a 4% decrease. Consolidated Profit After Tax (PAT) was ₹3.7 crore, a significant 63% decrease, and standalone PAT was ₹8.8 crore, a 39% decrease. These declines were attributed to increased overheads at Neogen Ionics, elevated insurance premiums post-fire incident, interim toll manufacturing expenses, and higher finance costs related to plant reconstruction and expansionary spends.
Key operational updates include the rapid progress in constructing the replacement plant for the Dahej facility, with commissioning scheduled for Q1 FY27. The company has received ₹83.48 crore in insurance claims related to the fire incident, with a net claim receivable of ₹251.12 crore.
In its Battery Chemicals business, Neogen Ionics is expanding its manufacturing setup. The company plans to establish capacities for Lithium Electrolyte Salts and Electrolytes, with significant expansions planned up to FY27. The aggregate CAPEX for these initiatives stands at ₹1,500 crore, with a peak revenue potential of ₹2,500 to ₹2,950 crore by FY29. A landmark Indo-Japan Joint Venture with Morita Investment Limited has been concluded for electrolyte salt production, with Neogen holding an 80% stake in the new entity, Neogen Morita New Materials Limited. This JV leverages Japanese technology to enhance production efficiency and access international markets, establishing India's only non-FEOC compliant electrolyte salt plant.
The company's Board has granted in-principle approval to raise up to ₹150 crore through a preferential issue of equity shares to the Promoter Group, subject to regulatory approvals. Management commentary highlights a steady recovery and a strategic pivot towards battery materials, leveraging proven Japanese technologies for cost-efficient lithium salt and electrolyte supply. The Pakhajan Greenfield Electrolyte plant is nearing mechanical completion, with trial production expected shortly.
Neogen Chemicals also emphasizes its commitment to sustainability, having achieved an EcoVadis Silver Medal for 2025. The company's CSR activities focus on education, water conservation, healthcare, women empowerment, and environment protection.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.